• A Mild Presentation of X-Linked Hypophosphatemia Caused by a Non-Canonical Splice Site Variant in the <em>PHEX</em> Gene
• A Novel Heterozygous Mutation c.1627G&gt;T (p.Gly543Cys) in the <em>SLC34A1</em> Gene in a Male Patient with Recurrent Nephrolithiasis and Early Onset Osteopenia: A Case Report
• Activin A: a marker of mineral bone disorder in children with chronic kidney disease?
• ACTUALITIES IN THE MANAGEMENT OF SECONDARY HYPERPARATHYROIDISM DUE TO CHRONIC KIDNEY DISEASE IN CHILDREN
• Advanced glycosylation end products promote the progression of CKD-MBD in rats, and its natural inhibitor, quercetin, mitigates disease progression
• Alteration of bone microarchitecture in hereditary distal RTA patients with SLC4A1 gene mutation: assessed by HR-pQCT
• An update on clinical presentation and responses to therapy of patients with hereditary hypophosphatemic rickets with hypercalciuria (HHRH)
• Anaesthetic concerns of a child with symptomatic vitamin D deficiency rickets with secondary hyperparathyroidism: A case report
• Application of artificial intelligence to chronic kidney disease mineral bone disorder
• Arthrogryposis, renal dysfunction, cholestasis syndrome with a novel mutation in two siblings
• Association between Chronic Kidney Disease-Mineral and Bone Disorder Biomarkers and Symptom Burden in Older Patients with Advanced Chronic Kidney Disease: Results from the EQUAL Study
• Association between serum magnesium levels and cognitive function in patients undergoing hemodialysis
• Band-shaped keratopathy in <em>HNF4A</em>-related Fanconi syndrome: a case report and review of the literature
• Bilateral Femoral Neck Fractures in a 50-Year-Old Patient with Chronic Kidney Disease
• Biomechanical and histomorphological analysis of the mandible in rats with chronic kidney disease
• Burosumab Efficacy and Safety in Patients with X-Linked Hypophosphatemia: Systematic Review and Meta-analysis of Real-World Data
• Cemented vertebra and adjacent vertebra refractured in a chronic kidney disease-mineral and bone disorder patient: A case report
• Chronic Kidney Disease-Mineral Bone Disorder (CKD-MBD)
• Clinical characteristics and genetic profile of children with WDR72-associated distal renal tubular acidosis: a nationwide experience
• Clinical, genetic profile and therapy evaluation of 11 Chinese pediatric patients with Fanconi-Bickel syndrome
• Complex phenotype in Fanconi renotubular syndrome type 1: Hypophosphatemic rickets as the predominant presentation
• Consenso mexicano de tirosinemia tipo 1
• Correlation between soluble klotho and chronic kidney disease-mineral and bone disorder in chronic kidney disease: a meta-analysis
• Corrigendum: Fucoidan ameliorates renal injury-related calcium-phosphorus metabolic disorder and bone abnormality in the CKD-MBD model rats by targeting FGF23-Klotho signaling axis
• Current therapeutic approach of chronic kidney disease-mineral and bone disorder
• Diabetes mellitus modifies the association between chronic kidney disease-mineral and bone disorder biomarkers and aortic stiffness in peritoneal dialysis patients
• Diagnosis, treatment, and management of rickets: a position statement from the Bone and Mineral Metabolism Group of the Italian Society of Pediatric Endocrinology and Diabetology
• Disease Manifestations and Complications in Dutch X-Linked Hypophosphatemia Patients
• Effect of Denosumab on Bone Health, Vascular Calcification, and Health-Related Quality of Life in Hemodialysis Patients with Osteoporosis: A Prospective Observational Study
• Efficacy and safety of burosumab compared with conventional therapy in patients with X-linked hypophosphatemia: A systematic review
• Efficacy and safety of denosumab treatment for Korean patients with Stage 3b-4 chronic kidney disease and osteoporosis
• Ethnic and seasonal variations in FGF-23 and markers of chronic kidney disease-mineral and bone disorder
• Etiology and Biochemical Profile of Rickets in Tertiary Care Centres in Eastern India: A Retrospective Cross-sectional Study
• Evaluation of dental manifestations in X-linked hypophosphatemia using orthopantomography
• Extrarenal complications of cystinosis
• Family analysis and literature study of hereditary hypophosphatemic rickets with hypercalciuria
• Fracture Management in Chronic Kidney Disease: Challenges and Considerations for Orthopedic Surgeons
• Genetic profile of a large Spanish cohort with hypercalcemia
• Genetics, X-Linked Inheritance
• Hereditary Hypophosphatemic Rickets with Hypercalciuria Presenting with Enthesopathy, Renal Cysts, and High Serum c-Terminal FGF23: Single-Center Experience and Systematic Review
• Hyperphosphatemia in Chronic Kidney Disease: The Search for New Treatment Paradigms and the Role of Tenapanor
• Hypophosphatemic rickets and short stature
• Impaired Growth Plate Maturation in XLH Is due to Both Excess FGF23 and Decreased 1,25-Dihydroxyvitamin D Signaling
• Impaired growth plate maturation in XLH is due to both excess FGF23 and decreased 1,25Dihydroxyvitamin D signaling
• Inherited Fanconi renotubular syndromes: unveiling the intricacies of hypophosphatemic rickets/osteomalacia
• Inherited non-FGF23-mediated phosphaturic disorders: A kidney-centric review
• Insight into the potential of bone turnover biomarkers: integration in the management of osteoporosis and chronic kidney disease-associated osteoporosis
• International variations in serum PTH and calcium levels and their mortality associations in peritoneal dialysis patients: Results from PDOPPS
• Lanthanum Hydroxide and Chronic Kidney Disease Mineral and Bone Disorder: A Rat Model
• Latin-American consensus on the transition into adult life of patients with X-linked hypophosphatemia
• Lessons learned from the real-world diagnosis and management of hereditary hypophosphatemic rickets
• Leveraging quantitative systems pharmacology and artificial intelligence to advance treatment of chronic kidney disease mineral bone disorder
• Machine learning based biomarker discovery for chronic kidney disease-mineral and bone disorder (CKD-MBD)
• Managing chronic kidney disease - mineral bone disorder among patients on maintenance haemodialysis by achieving serum calcium and phosphate targets - a quality improvement project
• Managing chronic kidney disease - mineral bone disorder among patients on maintenance haemodialysis by achieving serum calcium and phosphate targets - a quality improvement project
• Marked vascular calcification in a patient on hemodialysis
• Metabolomics of Plasma in XLH Patients with Arterial Hypertension: New Insights into the Underlying Mechanisms
• New Mutation of CYP24A1 in a Case of Idiopathic Infantile Hypercalcemia Diagnosed in Adulthood
• New triple therapy for the diagnosis of CKD-MBD: a cross-sectional study in Shanxi province
• Novel Biomarkers of Bone Metabolism
• Oh, My Gut! New insights on the role of the gastrointestinal tract and the gut microbiome in chronic kidney disease-mineral and bone disorder
• Osteoporosis in Renal Disease
• Osteoporosis management in patients with chronic kidney disease (ERCOS Study): A challenge in nephrological care
• OSTEOPROTEGERIN AS AN EARLY SIGN OF CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER
• Pathogenesis and Mechanism of Uremic Vascular Calcification
• Pediatric Renal Rickets at a Tertiary Center
• Phenotypes of Mineral Bone Disorder in Chronic Kidney Disease in a Dialysis Population
• Phosphate-sensing mechanisms and functions of phosphate as a first messenger
• Plasma activin A rises with declining kidney function and is independently associated with mortality in patients with chronic kidney disease
• Post-Transplant Bone Disease in Kidney Transplant Recipients: Diagnosis and Management
• Real-World Experience of Using Etelcalcetide for Secondary Hyperparathyroidism in Community-Based Hemodialysis Centers in Singapore
• Real-world usage of Chronic Kidney Disease - Mineral Bone Disorder (CKD-MBD) biomarkers in nephrology practices
• Recurrent Soft Tissue Infections Associated With Burosumab Therapy in X-Linked Hypophosphatemic Rickets
• Renal osteodystrophy and clinical outcomes: a prospective cohort study
• Rickets Types and Treatment with Vitamin D and Analogues
• Role of sphingolipid metabolism signaling in a novel mouse model of renal osteodystrophy based on transcriptomic approach
• Roles of Parathyroid Hormone and Fibroblast Growth Factor 23 in Advanced Chronic Kidney Disease
• Safety and efficacy of burosumab in improving phosphate metabolism, bone health, and quality of life in adolescents with X-linked hypophosphatemic rickets
• Safety of cinacalcet in children and adolescents with chronic kidney disease-mineral bone disorder: systematic review and proportional meta-analysis of case series
• Seeing the Whole Picture: Evaluating the Contribution of Whole Grains to Phosphorus Exposure in People With Kidney Failure Undergoing Dialysis Treatment
• Severe Hypocalcemia With Denosumab Among Older Female Dialysis-Dependent Patients
• Skeletal parathyroid hormone hyporesponsiveness: a neglected, but clinically relevant reality in chronic kidney disease
• Soluble Klotho, a Potential Biomarker of Chronic Kidney Disease-Mineral Bone Disorders Involved in Healthy Ageing: Lights and Shadows
• Study on the Effect of Low Calcium Dialysate on Biochemical Profile of Adynamic Bone Disease in Patients on Maintenance Hemodialysis
• Successful Burosumab Treatment in an Adult Patient with X-Linked Hypophosphatemia and Chronic Kidney Disease Stage 3b
• The 100 top-cited articles on chronic kidney disease-mineral and bone disorder: A bibliometric analysis
• The Bone-Vascular Axis in Chronic Kidney Disease: From Pathophysiology to Treatment
• The diagnostic odyssey in children and adolescents with X-linked hypophosphataemia: population-based, case-control study
• The Diagnostic Odyssey in Children and Adolescents With X-linked Hypophosphatemia: Population-Based, Case-Control Study
• The Dietary Fiber Inulin Slows Progression of Chronic Kidney Disease-Mineral Bone Disorder (CKD-MBD) in a Rat Model of CKD
• The Efficacy and Safety of High-Dose Cholecalciferol Therapy in Hemodialysis Patients
• The hidden and complex relationship between dietary phosphorus and malnutrition in hemodialysis patients with chronic kidney disease
• The role of irisin in kidney diseases
• Transformation of a long-standing phosphaturic tumor-inducing osteomalacia into malignancy
• Tubular phosphate transport: a comparison between different methods of urine sample collection in FGF23-dependent hypophosphatemic syndromes
• Understanding the Korean Dialysis Cohort for Mineral, Vascular Calcification, and Fracture (ORCHESTRA) Study: Design, Method, and Baseline Characteristics
• Utility of Blood Biomarkers to Predict Marrow Iron Stores in Children
• Vitamin D Metabolites Before and After Kidney Transplantation in Patients Who Are Anephric
• X-linked hypophosphatemia due to a de novo novel splice-site variant in a 7-year-old girl with scaphocephaly, Chiari syndrome type I and syringomyelia
• X-linked hypophosphatemic rickets and nephrocalcinosis: clinical characteristics of a single-center pediatric cohort in North America before and after burosumab